The ‘Omics Days’ conference was held over three days, with a rich and focused program, covering various Omics research topics at the forefront of AFBI’s current scientific interest and corporate ...

Chip giant NVIDIA has agreed a $2 billion partnership with AI cloud provider Nebius, a supplier to the life sciences industry and other sectors, focusing on the design and development of 'AI factories ...

The startup is developing AI foundation models trained on DNA rather than text or code, applying deep learning techniques to ...

Cancer immunology has rapidly evolved with the growing recognition that the immune response to cancer is governed by complex, multilayered regulatory ...

Element Biosciences AVITI24 5D Multiomic and AVITI next generation sequencing systems are designed to make high-performance genomics accessible to all. With its combination of accuracy, flexibility, ...

The AI in precision medicine market shows strong growth prospects driven by the need for personalized therapies amid rising chronic diseases. Key opportunities include advancements in AI for ...

The human lymphatic system is notoriously difficult to map due to its size and variability among individuals. Spatial ...

Cash Burn -- $50.2 million in 2025, an improvement from $57.8 million in 2024 due to lower headcount and development costs. 2026 Financial Guidance -- Operating expenses projected to rise 15%-20%, ...

Amydis Inc., a privately held clinical-stage company pioneering a platform of ocular tracers that enable imaging of disease-related molecular biomarkers in the eye, announced today a Phase 2 grant ...

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript February 26, 2026 Nautilus Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.11, expectations were $-0.14 ...

Systems biology modeling is entering a new phase. For decades, computational models—ODE and PDE systems, stochastic simulations, constraint-based networks, ...